Ocular Therapeutix GAAP EPS of -$0.42 misses by $0.06, revenue of $12.88M misses by $1.42M
- Ocular Therapeutix press release (OCUL): Q3 GAAP EPS of -$0.42 misses by $0.06.
- Revenue of $12.88M (-11.2% Y/Y) misses by $1.42M.
-
Selling and marketing expenses were $15.7 million for the third quarter of 2026, compared with $13.1 million for the comparable quarter of
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.